Myelitis  >>  Avonex (recombinant IFN-β-1a)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avonex (recombinant IFN-β-1a) / Biogen
NCT00001785: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)

Completed
2
12
US
Recombinant human interferon beta-1a
National Institute of Neurological Disorders and Stroke (NINDS)
HTLV-I Infection, Spinal Cord Disease, Tropical Spastic Paraparesis
 
09/04

Download Options